JBC Oz Biosciences

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M304221200 on May 21, 2003

J. Biol. Chem., Vol. 278, Issue 33, 31372-31379, August 15, 2003
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
278/33/31372    most recent
M304221200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tao, X.
Right arrow Articles by Tong, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tao, X.
Right arrow Articles by Tong, L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Crystal Structure of Human DJ-1, a Protein Associated with Early Onset Parkinson's Disease*

Xiao Tao and Liang Tong {ddagger}

From the Department of Biological Sciences, Columbia University, New York, New York 10027

Received for publication, April 22, 2003 , and in revised form, May 18, 2003.


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 
We report the crystal structure at 1.8-Å resolution of human DJ-1, which has been linked to early onset Parkinson's disease. The monomer of DJ-1 contains the {alpha}/{beta}-fold that is conserved among members of the DJ-1/ThiJ/PfpI superfamily. However, the structure also contains an extra helix at the C terminus, which mediates a novel mode of dimerization for the DJ-1 proteins. A putative active site has been identified near the dimer interface, and the residues Cys-106, His-126, and Glu-18 may play important roles in the catalysis by this protein. Studies with the disease-causing L166P mutant suggest that the mutation has disrupted the C-terminal region and the dimerization of the protein. The DJ-1 proteins may function only as dimers. The Lys to Arg mutation at residue 130, the site of sumoylation of DJ-1, has minimal impact on the structure of the protein.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 
Parkinson's disease (PD)1 is a common, progressive neurodegenerative disorder affecting roughly 1% of the population at the age of 65 (1). Clinically, PD generally presents with brady-kinesia, resting tremor, muscular rigidity, and postural instability. PD is a heterogeneous disease, and the majority of the cases appear to have sporadic origins. At the same time, the disorder can also be associated with specific genetic defects, especially for cases of familial PD (24). Ten different genetic loci have been linked with familial PD, and the genes responsible for PD at these loci include the presynaptic protein {alpha}-synuclein (5), parkin (6), and ubiquitin carboxyl-terminal hydrolase L1 (7).

Most recently, it was discovered that mutations in the DJ-1 gene are linked with autosomal recessive early onset familial PD (8). Two types of disruptions of this gene have been identified in PD patients. One is a deletion of several of its exons, which abolishes the production of the DJ-1 protein. The other disruption is a single point mutation, giving rise to the L166P mutant at the protein level. This mutant has a different cytoplasmic distribution and is believed to be functionally inactive. Therefore, loss of the normal function of DJ-1 appears to contribute to PD.

The exact biological function of the DJ-1 protein is currently unknown. It may play a role in the oxidative stress response, and this function could be important in preventing the onset of PD (8). Both {alpha}-synuclein and parkin participate in oxidative stress responses as well (9, 10). On the other hand, DJ-1 may also be associated with several other biological processes. It was first identified as an oncogene, because it can transform NIH3T3 cells in cooperation with the ras oncogene (11). The DJ-1 protein is also involved in the fertilization process in rat and mouse (1214). A significant reduction in the amount of this protein on the surface of sperm makes them unable to fertilize eggs (15). This finding suggests that the protein may be secreted under some circumstances, which has also been observed in breast cancers (16). Finally, DJ-1 was identified as the regulatory subunit of a 400-kDa RNA-binding protein complex and its presence inhibits the binding of RNA by the complex (17).

The DJ-1 protein is a positive regulator of the androgen receptor by sequestering its negative regulators PIASx{alpha} (protein inhibitor of activated STAT) or DJBP (DJ-1-binding protein) (18, 19). The activation of the androgen receptor might be related to the effects of this protein on fertility. PIAS proteins are SUMO-1 (small ubiquitin-like modifier-1) ligases and control their target proteins by sumoylation (20). It has been reported that PIASx{alpha} can sumoylate DJ-1 on the Lys-130 residue (18). DJBP is almost exclusively expressed in the testis in humans. It negatively modulates the androgen receptor by recruiting histone deacetylases. DJ-1 can inhibit this recruitment, thereby leading to the activation of the androgen receptor (19).

The human DJ-1 protein contains 189 amino acid residues. It belongs to the DJ-1/ThiJ/PfpI superfamily of proteins, which are conserved in many different organisms (Fig. 1). The function of ThiJ is currently unknown, although it might be related to the biosynthesis of thiamin (21, 22). PfpI is an intracellular protease that was first identified from the archaeon Pyrococcus furiosus (23), and it is present in most bacteria and archaea. The crystal structure of the closely related intracellular protease PH1704 from Pyrococcus horikoshii revealed the presence of a Cys-100/His-101/Glu-74' catalytic triad (primed residue indicate a different monomer) with the active site at the interface of neighboring monomers in a hexameric oligomer (24). A Cys-185/His-186/Asp-214 catalytic triad was found in a structural homolog of this protease, the heat shock protein Hsp31 from E. coli (25). The amino acid sequence of this chaperone, however, shares only a 19% identity with that of PH1704. The DJ-1/ThiJ/PfpI proteins also share limited sequence and structural homology to those of the type I glutamine amidotransferase (GAT) domains, which contain a Cys-His-Glu/Asp catalytic triad (26).



View larger version (50K):
[in this window]
[in a new window]
 
FIG. 1.
Amino acid sequences of the DJ-1/ThiJ/PfpI superfamily. The sequences of representative members of the three subfamilies are shown. A dot represents a deletion. The secondary structure (S.S.) elements in the DJ-1 structure are shown. Residues in the core of the DJ-1 monomer are colored in green, those in the dimer interface are in magenta, and those in the putative active site are in red.

 

Although the Cys residue in the active site of the PfpI proteases is conserved among all of the members of the DJ-1/ThiJ/PfpI superfamily, the His and Asp/Glu residues are not conserved in DJ-1 and its close homologs (Fig. 1). To determine the composition of this putative active site in DJ-1 and to obtain a better understanding for the possible molecular function of this protein, we have determined its crystal structure at a 1.8-Å resolution. We have also characterized the disease-causing L166P mutant in solution, which suggests that the DJ-1 protein may function only as a dimer.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 
Protein Expression and Purification—The gene for human DJ-1 was subcloned into the pET24d vector and overexpressed in E. coli at 20 °C. The recombinant protein contains a hexa-histidine tag at the C terminus. After cell lysis, the soluble protein was purified by nickel-agarose affinity, anion exchange, and gel-filtration chromatography. The protein was concentrated to 30 mg/ml in a buffer containing 20 mM Tris (pH 8.0), 150 mM NaCl, 3 mM DTT, and 5% (v/v) glycerol and stored at –80 °C. There are no Trp residues in DJ-1, and the protein concentration was determined by the Bradford method. The C-terminal His tag was not removed for crystallization.

For the production of selenomethionyl proteins, the expression construct was transformed into the methionine auxotroph E. coli DL41(DE3) cells. The bacterial growth was carried out in defined LeMaster media (27), and the protein was purified using the same protocol as for the wild-type protein.

Mutagenesis—The L166P and K130R single site mutants of human DJ-1 were created with the QuikChange kit (Stratagene) and sequenced to confirm the incorporation of the correct mutation. The mutant proteins were expressed in E. coli and purified following the same protocol as for the wild-type protein.

Protein Crystallization—Crystals of the DJ-1 wild-type and mutant proteins were prepared by the vapor diffusion method at 4 °C. Initial crystallization conditions for the wild-type protein were identified by sparse-matrix screening with commercial kits (Hampton Research). The reservoir solution contained 100 mM Tris (pH 8.0) and 10–12% (w/v) polyethylene glycol 3350. The protein was at a concentration of 15 mg/ml (diluted 1:1 with 30 mM Tris (pH 8.0) from the original stock). Both hexagonal bipyramid and plate crystals appeared overnight. They were cryoprotected with a solution containing 100 mM Tris (pH 8.0) and 35% (w/v) PEG3350 and flash-frozen in liquid propane. For crystals of the K130R mutant, the reservoir contained 100 mM Bis-Tris (pH 7.0), 20% (w/v) PEG3350, and 50 mM CaCl2. The protein was at 10 mg/ml concentration pre-mixed with 100 mM Bis-Tris (pH 5.5), 25% (w/v) PEG3350, and 200 mM ammonium acetate. Crystals in the shape of thin plates were cryoprotected with a solution containing 100 mM Bis-Tris (pH 7.0) and 35% (w/v) PEG3350 and flash-frozen in liquid propane for data collection at 100 K.

Data Collection and Processing—X-ray diffraction data were collected at 100 K on an ADSC (Area Detector Systems Corporation) CCD at the X4A beamline of Brookhaven National Laboratory. The diffraction images were processed and scaled with the HKL package (28). A selenomethionyl single wavelength anomalous diffraction data set to 1.8-Å resolution was collected on a hexagonal bipyramid crystal. It belongs to space group P3121, with one molecule in the asymmetric unit. The plate-shaped crystal of the wild-type protein belongs to space group P21 with four dimers in the asymmetric unit. A diffraction data set to 2.2-Å resolution was collected for this crystal. The K130R mutant crystal belongs to space group C2 with a dimer in the asymmetric unit. Its diffraction data set extended to 1.7-Å resolution. The data processing statistics are summarized in Table I.


View this table:
[in this window]
[in a new window]
 
TABLE I
Summary of crystallographic information

 

Structure Determination and Refinement—The locations of four Se atoms were determined with the program SnB (29). Reflection phases to 1.8-Å resolution were calculated based on the single wavelength anomalous diffraction data and improved with the program SOLVE (30), which also automatically located 80% of the residues in the molecule. The full atomic model was built into the electron density with the program O (31). The structures of the monoclinic crystal form and the K130R mutant were determined by the molecular replacement method with the program COMO (32). The structure refinement was carried out with the program CNS (33). The statistics on the structure refinement are summarized in Table I.


    RESULTS AND DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 
The Structure Determination—The crystal structure of wild-type human DJ-1 protein in a trigonal crystal form has been determined at 1.8-Å resolution by the selenomethionyl single wavelength anomalous diffraction method (34). The positions of the Se sites were determined by direct methods (29), which enabled the phasing of the reflections and automatic tracing of 80% of the residues in the protein (30). The current atomic model contains residues 2–188 of DJ-1 together with 199 water molecules. The last residue of the protein and the C-terminal hexa-histidine tag (LEHHHHHH) are not visible in the electron density map. The atomic model has excellent agreement with the experimental data with a R-factor of 19.0% (Table I). The r.m.s. deviation from ideal values in bond lengths and bond angles are 0.004 Å and 1.3°, respectively. All of the residues with the exception of Cys-106 are located in favored regions of the Ramachandran plot (data not shown). The Cys-106 residue has a strained main chain conformation (see below).

We have also determined the crystal structure at 2.2-Å resolution of the wild-type protein in a monoclinic crystal form (Table I) by the molecular replacement method (32, 35). This crystal contains four dimers of DJ-1 in the asymmetric unit, allowing us to assess the conformational flexibility of the monomer and dimer of DJ-1.

The structure of the K130R mutant of human DJ-1 has been determined at 1.7-Å resolution by the molecular replacement method (Table I). This crystal form is not isomorphous to either of the native crystals. The structure shows that the K130R side chains in both monomers are involved in crystal-packing interactions with neighboring dimers in the crystal, and these interactions are different from those for the Lys-130 side chain in the wild-type crystals.

Structure of the DJ-1 Monomer—The structure of the monomer of DJ-1 has the {alpha}/{beta}-fold with 11 {beta}-strands ({beta}1–{beta}11) and 8 {alpha}-helices ({alpha}A–{alpha}H) (Fig. 2A). The central {beta}-sheet of the structure contains seven strands. The six parallel strands of this sheet are arranged similar to those in the Rossmann-fold with the distinction that the third strand is very short in the DJ-1 structure ({beta}5 with only two residues) (Figs. 1 and 2A). Outside the central {beta}-sheet, strands {beta}3 and {beta}4 form a {beta}-hairpin structure and are involved in the dimerization of DJ-1 (see below). Strands {beta}8 and {beta}9 together with helix {alpha}F form a {beta}-{alpha}-{beta} motif, which contributes the conserved His-126 residue to the putative active site of DJ-1 (Fig. 2A).



View larger version (52K):
[in this window]
[in a new window]
 
FIG. 2.
Structure of the DJ-1 monomer. A, schematic drawing of the structure of DJ-1. The {beta}-strands are shown as arrowed ribbons in cyan, {alpha}-helices are in yellow, and the loops are in magenta. The side chains of residues Cys-106, His-126, and Glu-18 in the putative active site of the protein are shown in gray as well as the side chains of Lys-130 (green) and Leu-166 (red). B, structure of DJ-1 in a different view after 90° rotation around the horizontal axis. C, superposition of the structures of DJ-1 (in cyan) and PH1704 (in yellow). The {alpha}C' helix from another monomer in the structure of PH1704 is shown in green. The active site residues of DJ-1 and PH1704 are shown in gray and magenta, respectively. D, superposition of the structures of DJ-1 (in cyan) and the C-terminal domain of HPII (in yellow). The Cys and Asp residues in HPII are not conserved in the C-terminal domains of other catalases. This figure was produced with Ribbons (39).

 

Most of the helices flank the two faces of the {beta}-sheet (Fig. 2B). The only exception is helix {alpha}H at the extreme C terminus of DJ-1. It projects away from the rest of the protein and only contacts helices {alpha}A and {alpha}G in the monomer (Fig. 2B). Residues 181–187 in helix {alpha}H are conserved to be hydrophobic amino acids among the DJ-1 and ThiJ proteins (Fig. 1). These residues mediate the interactions with helices {alpha}A and {alpha}G as well as the dimerization of DJ-1 (see below).

The Dimer of DJ-1—Gel-filtration and light-scattering studies showed that wild-type DJ-1 protein exists as dimers in solution.2 In the trigonal crystal of the wild-type protein, there is a monomer of DJ-1 in the asymmetric unit. The other monomer of the dimer is related by the crystallographic 2-fold symmetry axis (Fig. 3A). The {alpha}A helices of the two monomers come into close contact in the core of the dimer (Fig. 3B). At one edge of the interface, the {beta}3-{beta}4 hairpin is situated right next to the dimer 2-fold axis, such that a four-stranded anti-parallel {beta}-sheet is formed across the dimer (Fig. 3A). At the other edge, the {beta}11-{alpha}G loop interacts with residues near the C terminus of the other monomer, including those in helix {alpha}H (Fig. 3B). These interactions may also be important to stabilize the conformation of the {alpha}H helix at the C terminus of DJ-1.



View larger version (39K):
[in this window]
[in a new window]
 
FIG. 3.
Structure of the DJ-1 dimer. A, schematic drawing in stereo of the dimer of DJ-1. One monomer is colored in cyan, whereas the other is in green. Secondary structure elements in the dimer interface are labeled. The side chains of residues Cys-106, His-126, and Glu-18 in the putative active site of the protein are also shown. B, structure of DJ-1 dimer in a different view after 90° rotation around the vertical axis. This figure was produced with Ribbons (39).

 

In the monoclinic crystal form of the wild-type protein, there are four dimers in the asymmetric unit. Structural comparisons among these dimers and the dimer in the trigonal crystal form show that the organizations of the dimers are essentially the same. The r.m.s. distance between equivalent C{alpha} atoms of any pair of these dimers is approximately 0.35 Å. The {alpha}B helix shows conformational variability among the four dimers in the monoclinic crystal, and this helix also has weak electron density in the trigonal crystal. The organization of the dimer is also conserved in that of the K130R mutant with a r.m.s. distance of 0.3 Å for 374 pairs of equivalent C{alpha} atoms of the wild-type and mutant dimers.

The DJ-1 dimer has an extensive interface between the two monomers. A total of 1200 Å2 of the surface area of each monomer is buried at this interface, involving mostly residues that are conserved among DJ-1 proteins (Fig. 1). Our structural and solution observations therefore suggest that this dimer is likely to be a stable and conserved oligomerization state for these proteins.

Interestingly, a deletion mutant of DJ-1 removing residues 178 to the C terminus (Fig. 1) is still mostly dimeric in solution (data not shown), suggesting that either the {alpha}H helix has a minor role in the dimerization of DJ-1 or the C-terminal hexahistidine tag (LEHHHHHH) is partially rescuing the dimer formation. On the other hand, the deletion mutant lacking residues 173 to the C terminus forms large aggregates of various sizes (molecular masses of 200–400 kDa) with little dimeric species in solution.

Structural Homologs of DJ-1—The structure of DJ-1 bears the strongest similarity to that of PH1704 from P. horikoshii (24), a member of the PfpI family, and the two proteins share 22% amino acid sequence identity. The r.m.s. distance is 1.1 Å for 137 equivalent C{alpha} atoms between DJ-1 and PH1704. Most of the secondary structure elements are superimposable between the two proteins (Fig. 2C). However, the {alpha}H helix at the C terminus of DJ-1 does not have a structural equivalent in PH1704. Sequence comparisons suggest that all of the PfpI family members lack this helix, because they are approximately 15 residues shorter than DJ-1 at the C terminus (Fig. 1).

The quaternary structure of PH1704 and DJ-1 are entirely different, despite the homology in the sequence and structure of their monomers. In contrast to the dimeric association of DJ-1, a hexameric structure roughly obeying 32 symmetry was observed in the crystal of PH1704 (24). This hexamer can be considered as a trimer of dimers, and the interface of the dimer is mediated by the {alpha}A and {alpha}G helices. However, such a mode of dimerization is not possible with DJ-1 as it is blocked by the extra {alpha}H helix in DJ-1. Therefore, the DJ-1 dimer is formed by a different arrangement of the {alpha}A and {alpha}G helices of the two monomers and the {alpha}H helices also contribute to the dimerization interface (Fig. 3A). In addition, the contribution of the {beta}3–{beta}4 hairpin to the dimer interface is unique to DJ-1 (Fig. 3A). The dimerization of Hsp31, a structural homolog of PH1704 and DJ-1, is mediated by segments outside the PfpI/DJ-1-fold (25).

Searches against the Protein Data Bank with the program Dali (36) showed that DJ-1 also shares significant structural similarity with the C-terminal domain in the catalase hydroperoxidase II (HPII) (37) as has been suggested earlier (26). The r.m.s. distance for 136 equivalent C{alpha} atoms between DJ-1 and this C-terminal domain (residues 600–753) is 2.0 Å. The amino acid identity for these residues is however only 12%. This domain in HPII lacks the {beta}8–{beta}10 insertion (Fig. 2D), which accounts for its smaller size. At the C terminus, HPII also has a helix but it is running in an opposite direction from the {alpha}H helix in DJ-1. The exact function of this C-terminal domain in HPII is not fully understood. It mediates the dimer interface in the tetramer of the enzyme and helps to form the substrate channel leading to the active site (37). This domain may also facilitate the folding of the full-length enzyme, as deletion mutants lacking this domain cannot accumulate in the cell. The dimerization of this domain in HPII uses the unique {alpha}H helix at the C terminus and is different from that in DJ-1.

Structural homology between the DJ-1/ThiJ/PfpI superfamily and the GAT domains has also been suggested earlier (26). However, the actual similarity is rather limited. The GAT domains lack the {beta}3–{beta}4 hairpin structure in DJ-1 but contain significantly more elaborate insertions between {alpha}E and {beta}10. Moreover, the binding site for glutamine in GAT is blocked by the {beta}6-{alpha}C loop in the DJ-1 structure. Therefore, it is unlikely that DJ-1 can have GAT function.

The Putative Catalytic Residues of DJ-1—The exact biochemical function of the DJ-1 protein is currently not known. However, structural and sequence comparisons with homologous proteins can provide valuable hints as to the possible roles of this protein in oxidative stress response, androgen receptor regulation, and other processes. A cysteine residue is conserved among all of the members of the DJ-1/ThiJ/PfpI superfamily, and the residue has been proposed as the catalytic nucleophile for the PfpI family of intracellular proteases (24). This residue is equivalent to Cys-106 in human DJ-1 (Fig. 1) and is located just after strand {beta}7 in the structure (Fig. 2A). The main chain of this residue assumes a strained conformation with {varphi} and {psi} torsion angles of 66 and –114°, respectively, which is also observed in the structures of PH1704 and Hsp31 (24, 25). The structural conservation of this Cys residue in DJ-1 suggests that it may also have a catalytic role in the biochemical function of this protein, identifying this region of the structure as the putative active site of DJ-1.

In both the PfpI proteases and the Hsp31 chaperone, the Cys residue is part of a Cys-His-Asp/Glu catalytic triad (24, 25). The second member His residue in the triad follows immediately after the Cys residue in the primary sequence of these proteins (Figs. 1 and 2C). In DJ-1, however, the residue immediately after Cys-106 is Ala (Fig. 1), signifying that there are differences between DJ-1 and the PfpI proteases in this active site. Our structures show that His-126, from the {beta}8-{alpha}F loop and conserved among all of the DJ-1 proteins (Fig. 1), is placed near the Cys-106 side chain in the putative active site of DJ-1 (Fig. 4A). The His-126 residue could be the second member of the catalytic machinery for DJ-1. The distance between the side chains of Cys-106 and His-126 is 4.2 Å in the current structure (Fig. 4A) similar to the distance of approximately 5 Å that is found in the active site of caspases (38).



View larger version (53K):
[in this window]
[in a new window]
 
FIG. 4.
The putative active site of DJ-1. A, schematic drawing of the structure near the Cys-106 residue of DJ-1. The two monomers are colored in green and cyan, respectively. B, molecular surface of the DJ-1 dimer near the putative active site. Panel A was produced with Ribbons (39), and panel B was produced with Grasp (40).

 

Simultaneous mutation of three residues of DJ-1, S57R, E96G, and H126Y can disrupt the interactions with PIASx{alpha} (18), providing support for the functional importance of the His-126 residue. However, all of the three residues are strictly conserved among the DJ-1 proteins (Fig. 1) and both Ser-57 and Glu-96 appear to have important structural roles as well. Therefore, it is not clear which of the three mutations is responsible for the loss of activity. The three residues are separated by ~25 Å from each other in the structure, so it is unlikely that they can all mediate the interactions with PI-ASx{alpha} at the same time.

In PH1704, the third member Glu residue of the catalytic triad comes from another monomer in the enzyme oligomer (Fig. 2C) (24), whereas in Hsp-31, the third member Asp residue comes from an inserted segment to the DJ-1/ThiJ/PfpI-fold (25). In our structures of DJ-1, no acidic residues are positioned near the His-126 side chain. The active site of the DJ-1 family members may contain only a Cys-His diad. With a cysteine residue as the nucleophile, it is known that a Cys-His diad is fully functional, for example, in the caspases.

On the other side of the Cys-106 residue, the side chain of Glu-18 is within 3.2 Å of the S{gamma} atom in the structure of DJ-1 (Fig. 4A). This Glu residue is strictly conserved among all of the DJ-1/ThiJ/PfpI proteins (Fig. 1), and it is also present in Hsp31. Moreover, the side chain of this residue is completely buried in the structure. Therefore, it is likely that this residue also has an important role in the biochemical functions of these proteins.

The Putative Active Site of DJ-1—The putative active site of DJ-1 is located near the interface of the dimer with contributions from residues in helices {alpha}A and {alpha}H of the other monomer (Fig. 4A). The two monomers of the dimer are arranged in a head-to-tail fashion, such that the two active sites are on opposite sides of the dimer (Fig. 3A). The Cys-106 residue lies in the center of a prominent surface depression in the structure (Fig. 4B). Residues in this active site are generally highly conserved including the 74GGNLGA79 motif ({beta}6-{alpha}C loop) and the 157GPG159 motif ({beta}8-{alpha}F loop) (Fig. 4A) that are conserved among the DJ-1 and ThiJ proteins (Fig. 1). The {alpha}A helix plays an especially important role in this active site. The Glu-18 residue is located near the N terminus of this helix, whereas Asp-24 and Arg-28 near its C terminus contribute to the other active site of the dimer (Fig. 4A).

Near Cys-106, there is a cluster of three acidic residues (Glu-15, Glu-16, and Asp-24') and two basic residues (Arg-48 and Arg-28') (Fig. 4A). These residues are highly conserved among all of the members of the DJ-1/ThiJ/PfpI superfamily (Fig. 1). The side chain of Glu-16 may stabilize the conformation of the {beta}3-{beta}4 hairpin by hydrogen bonding to residues 47 and 48 at its tip (Fig. 4A). Glu-15 is the N-terminal cap of helix {alpha}A and is hydrogen-bonded to the main chain amide of residue 17. In addition, this residue interacts with Asp-24' and Arg-28', helping the formation of the dimer. It is likely that Arg-48 and Arg-28' are involved in the binding of the substrate of this protein (Fig. 4A).

The Structure of the K130R Mutant, Site of Sumoylation—It has been reported that the Lys-130 residue can become sumoylated and that this modification is important for DJ-1 to achieve full activity in cell transformation (18). In the crystal structure, the Lys-130 residue is located at the beginning of helix {alpha}F, ~10 Å from the His-126 residue, and its side chain is completely exposed to the solvent (Fig. 5). Our structure of the K130R mutant of DJ-1 showed that the mutation has little impact on the structure of the protein itself. The Arg-130 side chains in the two monomers assume different conformations (Fig. 5), but this is probably due to the fact that the two Arg residues are involved in different crystal-packing contacts. The structural observation is consistent with the fact that the K130R mutation does not disrupt the interaction with the PIASx{alpha} protein (18).



View larger version (44K):
[in this window]
[in a new window]
 
FIG. 5.
Structure of the K130R mutant of DJ-1. Stereo drawing of the C{alpha} trace of the wild-type structure (in yellow) and the two monomers of the K130R mutant (green and cyan). The mutation site is labeled. The side chains of Cys-106 and His-126 are also shown. This figure was produced with Ribbons (39).

 

Studies on the Disease-causing L166P Mutant—The L166P mutation of human DJ-1 was first found in an Italian PD patient (8). This residue is strictly conserved among the DJ-1 proteins (8) as well as the ThiJ proteins, although it is not conserved among the PfpI proteases (Fig. 1). Based on sequence homology between DJ-1 and the PH1704 protease, it was suggested that the Leu-166 residue is located in a helix and the L166P mutation may disrupt the formation of this helix (8).

Our structural analyses confirm that Leu-166 is located in the center of helix {alpha}G (Fig. 2B). Moreover, our structures show that the side chain of this residue has a major role in forming the hydrophobic core between the extra {alpha}H helix at the C terminus and the {alpha}A and {alpha}G helices (Fig. 6). A total of 78 Å2 of the surface area of Leu-166 is buried at this interface. Therefore, the L166P mutation may have two effects on the structure of DJ-1 destabilization/unfolding of the {alpha}G helix and the disruption of the hydrophobic core among helices {alpha}A, {alpha}G, and {alpha}H.



View larger version (40K):
[in this window]
[in a new window]
 
FIG. 6.
The environment of the Leu-166 residue. Stereo drawing showing the hydrophobic core among helices {alpha}A, {alpha}G, and {alpha}H. The side chain of Leu-166 is shown in red. Residues Ile-168 and Leu-172 belong to the hydrophobic core with the central {beta}-sheet of the structure. This figure was produced with Ribbons (39).

 

To further characterize the structure of the L166P mutant, we have expressed it in E. coli and purified the soluble protein by nickel affinity, anion exchange, and gel filtration chromatography. Efforts at producing crystals of this mutant have so far been unsuccessful. Light-scattering studies with the purified protein show that the mutant is monomeric in solution. This is consistent with the structural analysis that the L166P mutation may lead to the unfolding of the C-terminal segment of DJ-1, which will also disrupt the formation of the dimer. These results suggest that the DJ-1 protein may only function as a dimer.

Functional Implications—Based on overall sequence homology, the DJ-1, ThiJ, and PfpI proteins have been grouped together into a superfamily. With the structural information on DJ-1 and PfpI (PH1704), it is clear that there are significant structural and sequence differences among the members of the superfamily. DJ-1 and ThiJ proteins may be more closely related to each other, whereas the PfpI proteins are more distant. Examination of the amino acid sequence conservation suggests that ThiJ proteins might also have the {alpha}H helix at the C terminus (Fig. 1) similar to DJ-1, whereas the PfpI proteins do not. The conservation of the Leu-166 residue in the DJ-1 and ThiJ proteins is probably related to the presence of this extra helix, because it is a crucial component of the hydrophobic core between this helix and the rest of the protein (Fig. 6). It is also possible that the ThiJ proteins will form the same dimer as DJ-1, in contrast to PH1704. The disease-causing effects of the L166P mutation in DJ-1 underscores the functional importance of the structural integrity of the C-terminal segment and indicates that these proteins may function only as dimers.

Another difference among members of this superfamily is that the active site His residue immediately follows the catalytic Cys nucleophile in the primary sequence only in the PfpI proteins. Although DJ-1 and ThiJ are similar in maintaining an Ala residue at this position in the primary sequence, the His-126 residue identified from our structural studies is conserved only in DJ-1. Based on the structural information and the sequence alignment, it is unlikely that the ThiJ proteins contain a His residue in the active site. However, the Glu-18 residue is still conserved in ThiJ.

DJ-1 has been associated with many different biochemical and biological functions. Our structural analysis suggests that DJ-1 may possess an active site and could also be a protease/hydrolase similar to the PfpI proteases. The relative positioning of the Cys-106 and His-126 residues are reminiscent of the active site of caspases. In addition, Arg-48 and Arg-28' residues are approximately 8 Å away from the Cys-106 residue in DJ-1, similar to the distances for the two Arg residues that recognize the P1 Asp residue in the substrate of caspases. It would be interesting to determine whether DJ-1 can recognize Asp residues in this putative active site.

The DJ-1 protein can also mediate interactions with other proteins such as PIASx{alpha}, DJBP, and the RNA-binding protein complex. It is not known whether the putative catalytic activity of DJ-1 is required for these interactions or whether a different surface patch can mediate these interactions. The structural conservation between DJ-1 and a domain that is crucial for the function of HPII and other catalases offers the tantalizing possibility that DJ-1 may also regulate the dismutation of peroxides. This could be the link between DJ-1 and the oxidative stress response.


    FOOTNOTES
 
The atomic coordinates and structure factors (code 1PDV [PDB] , 1PDW [PDB] , and 1PE0 [PDB] ) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).

* This work was supported by National Institutes of Health Grant AI49475 (to L. T.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

{ddagger} To whom correspondence should be addressed. Tel.: 212-854-5203; Fax: 212-854-5207; E-mail: tong{at}como.bio.columbia.edu.

1 The abbreviations used are: PD, Parkinson's disease; PIASx{alpha}, protein inhibitor of activated STAT; STAT, signal transducers and activators of transcription; DJBP, DJ-1-binding protein; GAT, glutamine amidotransferase; r.m.s., root mean square; HPII, hydroperoxidase II. Back

2 X. Tao and L. Tong, unpublished data. Back


    ACKNOWLEDGMENTS
 
We thank Javed Khan for help with data collection at the synchrotron radiation source and Randy Abramowitz and Xiaochun Yang for setting up the X4A beamline.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 

  1. Dawson, T. M., and Dawson, V. L. (2003) J. Clin. Invest. 111, 145–151[CrossRef][Medline] [Order article via Infotrieve]
  2. Gasser, T. (2001) J. Neurol. 248, 833–840[CrossRef][Medline] [Order article via Infotrieve]
  3. Giasson, B. I., and Lee, V. M.-Y. (2001) Neuron 31, 885–888[CrossRef][Medline] [Order article via Infotrieve]
  4. Cookson, M. R. (2003) Neuron 37, 7–10[CrossRef][Medline] [Order article via Infotrieve]
  5. Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E. S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W. G., Lazzarini, A. M., Duvoisin, R. C., di Iorio, G., Golbe, L. I., and Nussbaum, R. L. (1997) Science 276, 2045–2047[Abstract/Free Full Text]
  6. Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., and Shimizu, N. (1998) Nature 392, 605–608[CrossRef][Medline] [Order article via Infotrieve]
  7. Liu, Y., Fallon, L., Lashuel, H. A., Liu, Z., and Lansbury, P. T., Jr. (2002) Cell 111, 209–218[CrossRef][Medline] [Order article via Infotrieve]
  8. Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibanez, P., Joosse, M., van Dongen, J. W., Vanacore, N., van Swieten, J. C., Brice, A., Meco, G., van Duijn, C. M., Oostra, B. A., and Heutink, P. (2003) Science 299, 256–259[Abstract/Free Full Text]
  9. Hashimoto, M., Hsu, L. J., Rockenstein, E., Takenouchi, T., Mallory, M., and Masliah, E. (2002) J. Biol. Chem. 277, 11465–11472[Abstract/Free Full Text]
  10. Hyun, D.-H., Lee, M., Hattori, N., Kubo, S.-I., Mizuno, Y., Halliwell, B., and Jenner, P. (2002) J. Biol. Chem. 277, 28572–28577[Abstract/Free Full Text]
  11. Nagakubo, D., Taira, T., Kitaura, H., Ikeda, M., Tamai, K., Iguchi-Ariga, S. M. M., and Ariga, H. (1997) Biochem. Biophys. Res. Commun. 231, 509–513[CrossRef][Medline] [Order article via Infotrieve]
  12. Wagenfeld, A., Gromoll, J., and Cooper, T. G. (1998) Biochem. Biophys. Res. Commun. 251, 545–549[CrossRef][Medline] [Order article via Infotrieve]
  13. Welch, J. E., Barbee, R. R., Roberts, N. L., Suarez, J. D., and Klinefelter, G. R. (1998) J. Androl. 19, 385–393[Abstract/Free Full Text]
  14. Okada, M., Matsumoto, K.-I., Niki, T., Taira, T., Iguchi-Ariga, S. M. M., and Ariga, H. (2002) Biol. Pharm. Bull. 25, 853–856[CrossRef][Medline] [Order article via Infotrieve]
  15. Wagenfeld, A., Yeung, C.-H., Shivaji, S., Sundareswaran, V. R., Ariga, H., and Cooper, T. G. (2000) J. Androl. 21, 954–963[Abstract]
  16. Le Naour, F., Misek, D. E., Krause, M. C., Deneux, L., Giordano, T. J., Scholl, S., and Hanash, S. M. (2001) Clin. Cancer Res. 7, 3328–3335[Abstract/Free Full Text]
  17. Hod, Y., Pentyala, S. N., Whyard, T. C., and El-Maghrabi, M. R. (1999) J. Cell. Biochem. 72, 435–444[CrossRef][Medline] [Order article via Infotrieve]
  18. Takahashi, K., Taira, T., Niki, T., Seino, C., Iguchi-Ariga, S. M. M., and Ariga, H. (2001) J. Biol. Chem. 276, 37556–37563[Abstract/Free Full Text]
  19. Niki, T., Takahashi-Niki, K., Taira, T., Iguchi-Ariga, S. M. M., and Ariga, H. (2003) Mol. Cancer Res. 1, 247–261[Abstract/Free Full Text]
  20. Kotaja, N., Karvonen, U., Janne, O. A., and Palvimo, J. J. (2002) Mol. Cell. Biol. 22, 5222–5234[Abstract/Free Full Text]
  21. Mizote, T., Tsuda, M., Smith, D. D. S., Nakayama, H., and Nakazawa, T. (1999) Microbiology 145, 495–501[Abstract]
  22. Taylor, S. V., Kelleher, N. L., Kinsland, C., Chiu, H.-H., Costello, C. A., Backstrom, A. D., McLafferty, F. W., and Begley, T. P. (1998) J. Biol. Chem. 273, 16555–16560[Abstract/Free Full Text]
  23. Halio, S. B., Blumentals, I. I., Short, S. A., Merrill, B. M., and Kelly, R. M. (1996) J. Bacteriol. 178, 2605–2612[Abstract/Free Full Text]
  24. Du, X., Choi, I.-G., Kim, R., Wang, W., Jancarik, J., Yokota, H., and Kim, S.-H. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 14079–14084[Abstract/Free Full Text]
  25. Quigley, P. M., Korotkov, K., Baneyx, F., and Hol, W. G. J. (2003) Proc. Natl. Acad. Sci. U. S. A. 100, 3137–3142[Abstract/Free Full Text]
  26. Horvath, M. M., and Grishin, N. V. (2001) Proteins 42, 230–236[CrossRef][Medline] [Order article via Infotrieve]
  27. Hendrickson, W. A., Horton, J. R., and LeMaster, D. M. (1990) EMBO J. 9, 1665–1672[Medline] [Order article via Infotrieve]
  28. Otwinowski, Z., and Minor, W. (1997) Method Enzymol. 276, 307–326
  29. Weeks, C. M., and Miller, R. (1999) J. Appl. Crystallogr. 32, 120–124[CrossRef]
  30. Terwilliger, T. C., and Berendzen, J. (1999) Acta Crystallogr. Sec. D 55, 849–861[CrossRef][Medline] [Order article via Infotrieve]
  31. Jones, T. A., Zou, J. Y., Cowan, S. W., and Kjeldgaard, M. (1991) Acta Crystallogr. Sec. A 47, 110–119[CrossRef]
  32. Jogl, G., Tao, X., Xu, Y., and Tong, L. (2001) Acta Crystallogr. Sec. D 57, 1127–1134[CrossRef][Medline] [Order article via Infotrieve]
  33. Brunger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J.-S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T., and Warren, G. L. (1998) Acta Crystallogr. Sec. D 54, 905–921[CrossRef][Medline] [Order article via Infotrieve]
  34. Hendrickson, W. A. (1991) Science 254, 51–58[Abstract/Free Full Text]
  35. Rossmann, M. G. (1990) Acta Crystallogr. Sec. A 46, 73–82[CrossRef]
  36. Holm, L., and Sander, C. (1993) J. Mol. Biol. 233, 123–138[CrossRef][Medline] [Order article via Infotrieve]
  37. Bravo, J., Mate, M. J., Schneider, T., Switala, J., Wilson, K., Loewen, P. C., and Fita, I. (1999) Proteins 34, 155–166[CrossRef][Medline] [Order article via Infotrieve]
  38. Watt, W., Koeplinger, K. A., Mildner, A. M., Heinrikson, R. L., Tomasselli, A. G., and Watenpaugh, K. D. (1999) Structure 7, 1135–1143[Medline] [Order article via Infotrieve]
  39. Carson, M. (1987) J. Mol. Graphics 5, 103–106[Medline] [Order article via Infotrieve]
  40. Nicholls, A., Sharp, K. A., and Honig, B. (1991) Proteins 11, 281–296[CrossRef][Medline] [Order article via Infotrieve]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Protein Sci.Home page
G. Malgieri and D. Eliezer
Structural effects of Parkinson's disease linked DJ-1 mutations
Protein Sci., May 1, 2008; 17(5): 855 - 868.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
W. Yang, L. Chen, Y. Ding, X. Zhuang, and U. J. Kang
Paraquat induces dopaminergic dysfunction and proteasome impairment in DJ-1-deficient mice
Hum. Mol. Genet., December 1, 2007; 16(23): 2900 - 2910.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
E. Andres-Mateos, C. Perier, L. Zhang, B. Blanchard-Fillion, T. M. Greco, B. Thomas, H. S. Ko, M. Sasaki, H. Ischiropoulos, S. Przedborski, et al.
DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase
PNAS, September 11, 2007; 104(37): 14807 - 14812.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Gorner, E. Holtorf, J. Waak, T.-T. Pham, D. M. Vogt-Weisenhorn, W. Wurst, C. Haass, and P. J. Kahle
Structural Determinants of the C-terminal Helix-Kink-Helix Motif Essential for Protein Stability and Survival Promoting Activity of DJ-1
J. Biol. Chem., May 4, 2007; 282(18): 13680 - 13691.
[Abstract] [Full Text] [PDF]


Home page
Mol Biol EvolHome page
J. I. Lucas and I. Marin
A New Evolutionary Paradigm for the Parkinson Disease Gene DJ-1
Mol. Biol. Evol., February 1, 2007; 24(2): 551 - 561.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. C. Meulener, K. Xu, L. Thomson, H. Ischiropoulos, and N. M. Bonini
Mutational analysis of DJ-1 in Drosophila implicates functional inactivation by oxidative damage and aging
PNAS, August 15, 2006; 103(33): 12517 - 12522.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
B. Tang, H. Xiong, P. Sun, Y. Zhang, D. Wang, Z. Hu, Z. Zhu, H. Ma, Q. Pan, J.-h. Xia, et al.
Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease
Hum. Mol. Genet., June 1, 2006; 15(11): 1816 - 1825.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Choi, M. C. Sullards, J. A. Olzmann, H. D. Rees, S. T. Weintraub, D. E. Bostwick, M. Gearing, A. I. Levey, L.-S. Chin, and L. Li
Oxidative Damage of DJ-1 Is Linked to Sporadic Parkinson and Alzheimer Diseases
J. Biol. Chem., April 21, 2006; 281(16): 10816 - 10824.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Zhou and C. R. Freed
DJ-1 Up-regulates Glutathione Synthesis during Oxidative Stress and Inhibits A53T {alpha}-Synuclein Toxicity
J. Biol. Chem., December 30, 2005; 280(52): 43150 - 43158.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Yang, S. Gehrke, Md. E. Haque, Y. Imai, J. Kosek, L. Yang, M. F. Beal, I. Nishimura, K. Wakamatsu, S. Ito, et al.
Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling
PNAS, September 20, 2005; 102(38): 13670 - 13675.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Chen, B. Cagniard, T. Mathews, S. Jones, H. C. Koh, Y. Ding, P. M. Carvey, Z. Ling, U. J. Kang, and X. Zhuang
Age-dependent Motor Deficits and Dopaminergic Dysfunction in DJ-1 Null Mice
J. Biol. Chem., June 3, 2005; 280(22): 21418 - 21426.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol Genet